SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-017899
Filing Date
2020-04-22
Accepted
2020-04-22 15:26:21
Documents
8
Period of Report
2020-06-08
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A crtx-def14a_20191231.htm DEF 14A 480807
2 GRAPHIC gmcahm3t2kzp000002.jpg GRAPHIC 2108
3 GRAPHIC gmcahm3t2kzp000003.jpg GRAPHIC 2108
4 GRAPHIC gmcahm3t2kzp000005.jpg GRAPHIC 111787
5 GRAPHIC gmcahm3t2kzp000004.jpg GRAPHIC 2108
6 GRAPHIC gmcahm3t2kzp000001.jpg GRAPHIC 2514
7 GRAPHIC gmcahm3t2kzp000006.jpg GRAPHIC 97800
8 GRAPHIC gmcahm3t2kzp000007.jpg GRAPHIC 90332
  Complete submission text file 0001564590-20-017899.txt   908115
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38890 | Film No.: 20807877
SIC: 2836 Biological Products, (No Diagnostic Substances)